20 years studying p53 functions in genetically engineered mice

Lawrence A Donehower1, Guillermina Lozano

  • 1Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA. larryd@bcm.edu

Nature Reviews. Cancer
|September 25, 2009
PubMed

Insights

Genetically engineered mouse models reveal crucial insights into the tumor suppressor functions of the p53 protein. Studies show that mutations in the Trp53 gene accelerate cancer development in mice, highlighting p53

Area of Science:

  • Cell and molecular biology
  • Cancer research
  • Genetics

Background:

  • The tumor suppressor protein p53 plays a critical role in preventing cancer.
  • Understanding p53 function is essential for developing effective cancer therapies.
  • Genetically engineered mouse models offer a powerful platform for studying p53 in vivo.

Approach:

  • Utilized genetically engineered mouse models with targeted Trp53 gene mutations.
  • Compared cancer development rates in mice with wild-type and mutant Trp53 alleles.
  • Employed advanced genetic engineering techniques for precise manipulation of p53.

Key Points:

  • Mice with mutant Trp53 alleles exhibit accelerated development of various cancers.
  • These findings underscore the critical role of p53 as a tumor suppressor.
  • Sophisticated genetic engineering enables detailed study of p53 structure-function relationships.

Conclusions:

  • Genetically engineered mouse models are instrumental in advancing our understanding of p53 tumor suppressor functions.
  • Trp53 mutations are directly linked to increased cancer susceptibility and progression.
  • Future research can leverage these models to explore novel p53-based therapeutic strategies.